Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants

Z. A. Stewart, B. E. Lonze, D. S. Warren, N. N. Dagher, A. L. Singer, R. A. Montgomery, D. L. Segev

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Histidine-tryptophan-ketoglutarate (HTK) is associated with reduced graft survival of deceased donor kidney transplants'. Together they form a unique fingerprint.

Medicine & Life Sciences